Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Each blog post aims to inform readers about the health and economic benefits of research.  

Recent Blog Posts

Dear Research Advocate, This Saturday, advocates will celebrate science at events in Washington, D.C., and hundreds of cities across the globe to call attention to the value of science -- how it impacts our health, economy and planet. I encourage you to participate in the March for Science in your local communities and help us raise awareness of scientific progress. Our new video featuring one of our science fellows will be shown on jumbotrons on the National Mall in D.C. during the event. Read more about this celebration in our Board Chair’s statement , my op-ed in the Miami Herald and an LTE by Research!America’s Suzanne Ffolkes in the Hartford Courant. The March is the beginning of a...
Dear Research Advocate, The federal budget expires in 15 days. Reportedly, the ink is dry on a fiscal year 2017 (FY17) omnibus bill that includes an additional $2 billion for NIH ($1.7 billion for the base budget, and $300 million from the 21st Century Cures fund) and modest increases for most other science agencies. However, Office of Management and Budget (OMB) Director Mick Mulvaney tweeted this morning that the President may force a government shutdown if the bill doesn’t reflect his priorities. If ever there was a time to speak up, it’s now. We cannot condone, through our silence, OMB’s laundry list of proposed reductions to FY17 spending levels, much less the chaos of a government...
The April 2017 Research Advocate is now online . Highlights from this month include: Honorees at Research!America’s 21 st Annual Advocacy Awards Dinner on Wednesday, March 15 in Washington, D.C. exemplify the steadfast commitment of advocates for research in defeating disease and strengthening our nation’s preeminence in science and innovation. For a special insert of the 2017 Advocacy Awards dinner and honorees, click here . Medical research not only benefits the health of individuals, it benefits communities and the local economy, said Rep. David McKinley (R-WV-01) during Research!America’s 28 th Annual Meeting of Members on Wednesday, March 15 in Washington, D.C. “We know that the NIH...
Dear Research Advocate, Congress is making progress in reauthorizing the FDA user fee programs, which is good news. According to officials at FDA, if the July 31 deadline for the “UFA” reauthorizations is missed, “reduction in force” (RIF) notices will be sent to one-third of the staff who review medical devices and a full 70% of those who review “small molecule” prescription drugs. The impact would probably be at least that dramatic for CBER, the center that reviews biologics. If the process stalls (or looks likely to), we’ll let you know and provide advocacy options! During his confirmation hearing before the Senate HELP committee yesterday, FDA Commissioner nominee Dr. Scott Gottlieb...
On April 22, I will be at the March for Science Los Angeles, engaging with fellow scientists and advocates as a biochemist and communications intern with Research!America, a nonprofit advocacy alliance, to raise awareness about the important and exciting biomedical research taking place across the country and the need for increased federal funding. The march is a celebration of the countless ways in which research and innovation impacts society and touches our daily lives. As a graduate student in biochemistry, I conducted federally-funded research at the Geisel School of Medicine at Dartmouth College, studying component parts to recreate the molecular machines that are at work inside our...
March has been National Autoimmune Disease Awareness month, a month dedicated to increasing awareness and bringing greater focus to the myriad of immune diseases that affect more than 50 million Americans. At Janssen, we are focused on deepening our understanding of such complex diseases and advancing science to discover and develop innovative therapies for people living with immunologic diseases, while we also work toward a future where we hope to eliminate many of these devastating diseases altogether. I was honored to be part of a panel discussion on March 15th at the Research!America 28th Annual Meeting of Members in Washington, D.C. on the topic of lupus, an immune-mediated disease...
Dear Research Advocate, OMB has recommended cuts to FY17 appropriations , which would precede, if you will, the proposed FY18 cuts. As noted in our statement , these proposed cuts contradict worthy goals the President established for his tenure in office. They also fly in the face of public opinion. Fortunately, it appears Congress is not playing ball . Please use this editable message to say no to reductions and yes to passage of an FY17 omnibus bill. Reliable sources say the bill includes a $2 billion boost for NIH, as well as increases for CDC, FDA and NSF. The media is chock-full of commentary and quotes supporting investment in research and public health. A masterful Washington Post op...
Public support for medical and health research remains strong even during times of transition in government. In the newly released America Speaks , Vol. 17, Research!America’s compilation of recent public opinion survey data, 80 percent of Americans say it’s important for President Trump to assign a high priority to putting health research and innovation to work to assure continued medical progress. A majority of Americans (52%) are also willing to pay $1 per week more in taxes if they were certain that all of the money would be spent on additional medical research. The survey booklet covers a variety of topics including public opinion on national priorities for 2017, research and public...
Dear Research Advocate, Just as attention was shifting to the FY18 budget year, we are hearing that a year-long continuing resolution is not a forgone conclusion for FY17. We understand that the pending FY17 omnibus package includes a $2 billion increase for NIH as well as increases for CDC, NSF and FDA (unfortunately not AHRQ). This is a tight window of opportunity -- members of Congress must hear from you now in support of passing an FY17 omnibus bill. As for FY18, as I noted last week, the President’s budget blueprint proposed deep cuts to NIH and our other research agencies. Since then, the high volume of bipartisan cries of outrage may signal better funding outcomes in Congress,...
“We are on the cusp of a major breakthrough in medical progress, this is not a time to let up, it’s a time to redouble our efforts,” said Joe Biden , 47th Vice President of the United States, in his remarks at Research!America’s 21st Advocacy Awards Dinner on March 15. “We can make sure many more chronic diseases don’t cost you your life, but only if we break down barriers. I see the day a patient is given the right therapy the first time when they are diagnosed. I see the day when prevention is more effective, and where care is personalized and more effective with less side effects.” Former Vice President Biden received the Gordon and Llura Gund Leadership Award for his commitment to...

Pages

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America